- July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has received its production run of approximately 20,000 units of its BPC-157 transdermal patch (the "Patch"), the Company's lead product candidate
Please inquire with us if your country or region is not listed: Asia: Afghanistan, Israel, Jordan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc
Antioxidants, both conventional and emerging, have been shown to counteract these effects, offering therapeutic and preventive value
Oral supplementation research: The peptide fragments are degraded by digestive enzymes